Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

OCTRU is running a one-day course for those wishing to be a chief investigator on the design and conduct of clinical trials on Friday 10th June 2016 at the Botnar Research Centre.

The Oxford skyline

Aim: To provide those wishing to be a chief investigator with a greater understanding of how to design and conduct their own clinical trial and the secrets of a successful funding application.

 

Course objectives:

  • To understand how to develop a good research question
  • To explore the principles of good trial design
  • To know where to apply for trial funding
  • To understand how to write a successful funding application
  • To know how to effectively cost a trial
  • To understand the role of a Clinical Trials Unit

 

Venue: Botnar Research Centre, University of Oxford, Windmill Road, Oxford, OX3 7LF

Target audience: This course is specifically targeted at new investigators who would like to design and conduct their own trial but who have not yet successfully applied for funding.

Cost: £75 

CPD Credits: Approved by the Federation of the Royal College of Physicians for 5 category 1 (external) CPD credit(s)

 

Please note places are limited. Please email octrutrialshub@ndorms.ox.ac.uk for further details.

Similar stories

WHiTE Four trial results!

OCTRU

The WHiTE Four trial has now published its results in The Bone & Joint journal.

FUTURE GB Trial opens to recruitment!

OCTRU

The FUTURE GB Trial has received OCTRU Green Light approval and is now open to recruitment!

ARCADIAN trial opens to recruitment!

OCTRU

The ARCADIAN trial has received OCTRU Green Light approval and has now begun to open sites to recruitment!

HOPE-e study resumes recruitment of women with painful osteoarthritis in the hand

Main OCTRU

Researchers in Oxford are looking to recruit women who have painful osteoarthritis in joints of their hands, after resuming a study that was paused due to the COVID crisis.

HUSH trial opens to recruitment!

OCTRU

The HUSH trial has received OCTRU Green Light approval and is now open to recruitment!

Oxford researchers start new trial on the use of anti-TNF to treat Covid-19 in care homes

Main OCTRU Trials

Researchers at the University of Oxford are starting a new study to explore the effectiveness of the anti-tumour necrosis factor (anti-TNF) drug adalimumab as a treatment for patients with COVID-19 in the community, especially care homes. The AVID-CC trial, which will be conducted by Oxford Clinical Trials Research Unit (OCTRU), will enrol up to 750 patients from community care settings throughout the UK.